HUMDX
Price
$16.15
Change
-$0.52 (-3.12%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

HUMDX vs VSIAX

Header iconHUMDX vs VSIAX Comparison
Open Charts HUMDX vs VSIAXBanner chart's image
Huber Mid Cap Value I
Price$16.15
Change-$0.52 (-3.12%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
HUMDX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HUMDX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HUMDX is a StrongBuy and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. HUMDX (11.6M). VSIAX pays higher dividends than HUMDX: VSIAX (2.01) vs HUMDX (1.07). HUMDX was incepted earlier than VSIAX: HUMDX (9 years) vs VSIAX (13 years). HUMDX is a more actively managed with annual turnover of: 66.66 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than HUMDX: VSIAX (3000) vs HUMDX (5000). VSIAX (16.23) and HUMDX (15.96) have marching annual gain over last year. VSIAX return over 5 years is better than : 52.83 vs. HUMDX (34.23).
HUMDXVSIAXHUMDX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD14.22615.03195%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets11.6M63B0%
Annual Yield % from dividends1.072.0153%
Returns for 1 year15.9616.2398%
Returns for 3 years19.7220.6795%
Returns for 5 years34.2352.8365%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics